Partial Pancreatic Parenchymal Atrophy Is a New Specific Finding to Diagnose Small Pancreatic Cancer (≤10 mm) Including Carcinoma in Situ: Comparison with Localized Benign Main Pancreatic Duct Stenosis Patients
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Background: This study aimed to evaluate and identify the specific CT findings by focusing on abnormalities in the main pancreatic duct (MPD) and pancreatic parenchyma in patients with small pancreatic cancer (PC) including carcinoma in situ (CIS). Methods: Nine CT findings indicating abnormalities of MPD and pancreatic parenchyma were selected as candidate findings for the presence of small PC ≤ 10 mm. The proportions of patients positive for each finding were compared between small PC and benign MPD stenosis groups. Interobserver agreement between two independent image reviewers was evaluated using kappa statistics. Results: The final analysis included 24 patients with small PC (including 11 CIS patients) and 28 patients with benign MPD stenosis. The proportion of patients exhibiting partial pancreatic parenchymal atrophy (PPA) corresponding to the distribution of MPD stenosis (45.8% vs. 7.1%, p < 0.01), upstream PPA arising from the site of MPD stenosis (33.3% vs. 3.6%, p = 0.01), and MPD abrupt stenosis (45.8% vs. 14.3%, p = 0.03) was significantly higher in the small PC group than in the benign MPD stenosis group. Conclusions: The presence of partial PPA, upstream PPA, and MPD abrupt stenosis on a CT image was highly suggestive of the presence of small PCs including CIS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“FPA is sometimes detected in healthy subjects and those with benign diseases, ranging from 7.8% to 15.8% [13,14,15].”
From Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with Pancreatic Cancer: A Case-Control Study (2021) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pathological examination of the resected pancreatic tissue has revealed that FPA is associated with the loss of acinar cells and the subsequent replacement by fat or fibrosis [13,14,15].”
From Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with Pancreatic Cancer: A Case-Control Study (2021) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Distal parenchymal atrophy was present in 4% of controls without pancreatic diseases (11,35) and in 7.1–15.8% of patients with benign main pancreatic duct stricture (32,34,36).”
From Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer (2023) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The incidence of pancreatic parenchymal atrophy in pancreatic cancer varies from 13.3% to 53.0% (34).”
From Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer (2023) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Distal parenchymal atrophy is another characteristic feature of early pancreatic cancer and may be associated with a hypoattenuating mass or focal pancreatic duct dilatation (11,32,34).”
From Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer (2023) · cites this paper as [34]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Japan Pancreatic Cancer Registry; 30th Year Anniversary: Japan Pancreas Society
Egawa, S., Toma, H., Ohigashi, H., Okusaka, T., Nakao, A., Hatori, T., Maguchi, H., Yanagisawa, A., & Tanaka, M. (2012) · Pancreas · doi:10.1097/mpa.0b013e318258055c · Cited by 434
Imaging diagnosis of pancreatic cancer: A state-of-the-art review
Lee, E. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7864 · Cited by 401
(2006) · PubMed · Cited by 347
Multicenter study of early pancreatic cancer in Japan
Kanno, A., Masamune, A., Hanada, K., Maguchi, H., Shimizu, Y., Ueki, T., Hasebe, O., Ohtsuka, T., Nakamura, M., Takenaka, M., et al. (2018) · Pancreatology · doi:10.1016/j.pan.2017.11.007 · Cited by 291 · cited 4×
“[2], in which MPD dilation was seen in 79.”
BackgroundResultSelf-citationDeWitt, J., Devereaux, B. M., Lehman, G. A., Sherman, S., & Imperiale, T. F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.02.020 · Cited by 267
Yoon, S. H., Lee, J. M., Cho, J. Y., Lee, K. B., Kim, J. E., Moon, S. K., Kim, S. J., Baek, J. H., Kim, S. H., Kim, S. H., et al. (2011) · Radiology · doi:10.1148/radiol.11101133 · Cited by 257
Gangi, S., Fletcher, J. G., Nathan, M. A., Christensen, J. A., Harmsen, W. S., Crownhart, B. S., & Chari, S. T. (2004) · American Journal of Roentgenology · doi:10.2214/ajr.182.4.1820897 · Cited by 249
Kim, J. H., Park, S. H., Yu, E. S., Kim, M.-H., Kim, J., Byun, J. H., Lee, S. S., Hwang, H. J., Hwang, J.-Y., Lee, S. S., et al. (2010) · Radiology · doi:10.1148/radiol.10100015 · Cited by 249
Chen, J., Yang, R., Lu, Y., Xia, Y., & Zhou, H. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1268-1 · Cited by 186
Research works printed but not linked: 1
- Zaheer, 2014, Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography, J. Comput. Assist. Tomogr., 38, 146
Cited by
Toshima, F., Watanabe, R., Inoue, D., Yoneda, N., Yamamoto, T., Sasahira, N., Sasaki, T., Matsuyama, M., Minehiro, K., Tateishi, U., et al. (2021) · American Journal of Roentgenology · doi:10.2214/ajr.21.26014 · Cited by 81
Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma
Nakaoka, K., Ohno, E., Kawabe, N., Kuzuya, T., Funasaka, K., Nakagawa, Y., Nagasaka, M., Ishikawa, T., Watanabe, A., Tochio, T., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13020215 · Cited by 64
Ikemoto, J., Serikawa, M., Hanada, K., Eguchi, N., Sasaki, T., Fujimoto, Y., Sugiyama, S., Yamaguchi, A., Noma, B., Kamigaki, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11020287 · Cited by 54
Endoscopic approach in the diagnosis of high‐grade pancreatic intraepithelial neoplasia
Hanada, K., Shimizu, A., Kurihara, K., Ikeda, M., Yamamoto, T., Okuda, Y., & Tazuma, S. (2022) · Digestive Endoscopy · doi:10.1111/den.14240 · Cited by 51
Sagami, R., Yamao, K., Nakahodo, J., Minami, R., Tsurusaki, M., Murakami, K., & Amano, Y. (2021) · Cancers · doi:10.3390/cancers13050945 · Cited by 47
Self-citation
Metadata
- Authors
- Yamao, K., Takenaka, M., Ishikawa, R., Okamoto, A., Yamazaki, T., Nakai, A., Omoto, S., Kamata, K., Minaga, K., Matsumoto, I., Takeyama, Y., Numoto, I., Tsurusaki, M., Chikugo, T., Chiba, Y., Watanabe, T., & Kudo, M.
- Affiliations
- Kindai University (JP)
- Corresponding author
- Yamao, Kentaro
- ORCID
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2020-07-01
- Volume
- 10
- Issue
- 7
- Pages
- 445
- ISSN
- 2075-4418 (ISSN-L)
- PMC
- PMC7400308
- OpenAlex
- W3038994021
- Cited by
- 58
- References
- 35
- Citations by year
- 2026: 12 · 2025: 10 · 2024: 11 · 2023: 9 · 2022: 8 · 2021: 8
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diagnostics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- small pancreatic cancer, carcinoma in situ, main pancreatic duct stenosis, computed tomography findings, diagnostic specificity, interobserver agreement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Partial Pancreatic Parenchymal Atrophy Is a New Specific Finding to Diagnose Small Pancreatic Cancer (≤10 mm) Including Carcinoma in Situ: Comparison with Localized Benign Main Pancreatic Duct Stenosis Patients. https://app.cochat.ai/papers/10.3390/diagnostics10070445
- The paper
- Yamao, K., Takenaka, M., Ishikawa, R., Okamoto, A., Yamazaki, T., Nakai, A., Omoto, S., Kamata, K., Minaga, K., Matsumoto, I., Takeyama, Y., Numoto, I., Tsurusaki, M., Chikugo, T., Chiba, Y., Watanabe, T., & Kudo, M. (2020). Partial Pancreatic Parenchymal Atrophy Is a New Specific Finding to Diagnose Small Pancreatic Cancer (≤10 mm) Including Carcinoma in Situ: Comparison with Localized Benign Main Pancreatic Duct Stenosis Patients. Diagnostics. https://doi.org/10.3390/diagnostics10070445
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.